| 價格 | 詢價 |
| 包裝 | 1支 |
| 最小起訂量 | 1支 |
| 發(fā)貨地 | 湖北 |
| 更新日期 | 2026-07-08 |
| 中文名稱:重組小鼠CD30 (C-6His)蛋白 | 英文名稱:Recombinant Mouse CD30 (C-6His) |
| 品牌: EnkiLife | 產(chǎn)地: 中國 |
| 保存條件: Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles. | 產(chǎn)品類別: 重組蛋白 |
| 是否進(jìn)口: 否 | 用途: 科研 |
| 產(chǎn)品名稱 |
Recombinant Mouse CD30 (C-6His) |
| 英文名稱 |
CD30/TNFRSF8/CD30L Receptor/Tumor necrosis factor receptor superfamily member 8/Ki-1 antigen/Lymphocyte activation antigen CD30 |
| 純度 |
Greater than 95% as determined by reducing SDS-PAGE |
| 內(nèi)毒素 |
<1 EU/μg as determined by LAL test. |
| 蛋白構(gòu)建 |
Recombinant Mouse TNF Receptor Superfamily Member 8 is produced by our Mammalian expression system and the target gene encoding Phe19-Thr281 is expressed with a 6His tag at the C-terminus. |
| Accession |
Q60846 |
| 表達(dá)宿主 |
Human Cells |
| 種屬 |
Mouse |
| 預(yù)測分子量 |
28.4 KDa |
| 制劑 |
Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4. |
| 運(yùn)輸方式 |
The product is shipped at ambient temperature.Upon receipt, store it immediately at the temperature listed below. |
| 穩(wěn)定性&儲存 |
Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles. |
| 復(fù)溶 |
Always centrifuge tubes before opening.Do not mix by vortex or pipetting.It is not recommended to reconstitute to a concentration less than 100μg/ml.Dissolve the lyophilized protein in distilled water.Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
| 分子別名 |
| Tumor necrosis factor receptor superfamily member 8; CD30L receptor; Lymphocyte activation antigen CD30; CD30; Tnfrsf8 |
| 背景介紹 |
| CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor family, which regulates proliferation/apoptosis and antibody responses. CD30 is expressed by activated, but not by resting, T and B cells. Aberrant expression of CD30 by mastocytosis mast cells and interaction with its ligand CD30L (CD153) appears to play an important role in the pathogenesis and clinical presentation of systemic mastocytosis. CD30 has been considered as a specific diagnostic biomarker of anaplastic large cell lymphoma (ALCL) and classical Hodgkin lymphoma (cHL). CD30 is also a biomarker used for targeted therapy by an antibody–drug conjugate. Soluble CD30 retains the ability to bind CD30 Ligand and functions as an inhibitor of normal CD30 signaling. |
注意事項
本司產(chǎn)品僅用于科研,不用于臨床診斷和治療
| 成立日期 | 2024-08-02 (2年) | 注冊資本 | 271萬人民幣 |
| 員工人數(shù) | 10-50人 | 年營業(yè)額 | ¥ 100萬-300萬 |
| 主營行業(yè) | 生化試劑,抗體,細(xì)胞培養(yǎng),癌癥研究,細(xì)胞生物學(xué) | 經(jīng)營模式 | 工廠,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
|---|---|---|---|---|
| ¥2348 |
VIP5年
|
上海博爾森生物科技有限公司
|
2026-07-27 | |
| ¥2460 |
VIP7年
|
上海澤葉生物科技有限公司
|
2026-07-27 | |
| ¥3200 |
VIP1年
|
上海研生實(shí)業(yè)有限公司
|
2026-07-24 |